ALMED - Company finances
|
EUR
|
2018
From: 2018-09-04
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 156,309 | 1,649,457 | 2,023,506 | 2,595,939 | 2,462,439 | 2,689,935 | 2,439,617 | 2,582,781 |
| Profit before tax | - | 256,029 | 392,670 | 458,365 | 534,544 | 283,774 | 256,360 | 258,164 |
| Net profit | 36,349 | 156,821 | 295,367 | 297,247 | 400,611 | 120,492 | 105,589 | 98,410 |
| Equity | 38,849 | 195,671 | 896,391 | 1,463,638 | 809,018 | 929,509 | 1,913,731 | 2,272,141 |
| Liabilities | 149,986 | 382,142 | 326,934 | 515,224 | 593,049 | 536,973 | 593,371 | 730,390 |
| Non-current assets | 0 | 19,452 | 32,683 | 81,977 | 82,462 | 23,008 | 32,771 | 19,162 |
| Current assets | 188,835 | 558,361 | 1,190,642 | 1,895,728 | 1,313,311 | 1,439,201 | 2,472,579 | 2,982,556 |
| Total assets | 188,835 | 577,813 | 1,223,325 | 1,977,705 | 1,395,773 | 1,462,209 | 2,505,350 | 3,001,718 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 323,210 | 312,200 | 335,756 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +955.3% | +22.7% | +28.3% | -5.1% | +9.2% | -9.3% | +5.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 19.2% | 27.1% | 24.1% | 15.0% | 28.7% | 8.2% | 4.2% | 3.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 93.6% | 80.1% | 33.0% | 20.3% | 49.5% | 13.0% | 5.5% | 4.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 23.3% | 9.5% | 14.6% | 11.5% | 16.3% | 4.5% | 4.3% | 3.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 15.5% | 19.4% | 17.7% | 21.7% | 10.5% | 10.5% | 10.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.9 | 2.0 | 0.4 | 0.4 | 0.7 | 0.6 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 78,155 | 860,571 | 1,011,753 | 1,297,970 | 1,231,220 | 1,344,968 | 1,722,042 | 2,582,781 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ALMED - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-12-17 | 2024-12-20 | 700.90 |
ALMED - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ALMED, UAB (code 304912881) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.58M, up 5.9% year on year from €2.44M in 2024, while still remaining below the €2.69M recorded in 2023. Net profit declined to €98.4K in 2025 from €105.6K in 2024 and €120.5K in 2023, and the net profit margin narrowed to 3.8% from 4.3% and 4.5% in the prior two years. The business therefore showed moderate revenue recovery in 2025, but profitability continued to soften. Balance-sheet size expanded further, with total assets reaching €3.00M at the end of 2025, compared with €2.51M in 2024 and €1.46M in 2023. Equity increased to €2.27M, while liabilities rose to €730.4K. The equity ratio stood at 75.7%, debt-to-equity at 0.32, ROE at 4.3%, ROA at 3.3%, and asset turnover at 0.86x. Revenue per employee was €2.58M in 2025.